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Carbon nanotubes (CNTs) have been widely explored for use in




3,4 and cancer cell targeting.
5 However, their inherent
cytotoxicity has imposed limitations on their use as biological
probes and in therapeutic composites.
6-9 The cytotoxicity of CNTs
can be reduced by surface functionalization,
5,10-12 but the pos-
sibility of in situ desorption brings considerable risk to their use in
living organisms. Here we report that boron nitride nanotubes
(BNNTs), isosteres of CNTs with unique physical properties, are
inherently noncytotoxic. Furthermore, BNNTs can be surface
functionalized with biological epitopes that mediate protein and
cell binding. Finally, we show that BNNTs can deliver DNA
oligomers to the interior of cells with no apparent toxicity. This
work suggests that BNNTs may be superior to CNTs for use as
biological probes and in biomaterials.
Boron nitride is isoelectronic to carbon and has a stable hexagonal
structure analogous to that of graphite. The existence of BNNTs
was predicted theoretically in 1994,
13,14 and they were synthesized
shortly thereafter.
15 In addition to their structural similarity, BNNTs
and CNTs have similar mechanical properties and thermal
conductivity.
16,17 However, BNNTs are distinct in several key
aspects. First, BNNTs are wide band gap semiconductors whose
electrical properties are independent of geometry, while CNTs may
be metal or semiconducting depending on chirality and diameter.
Second, BNNTs are more chemically inert and structurally stable
than CNTs. This latter property prompted us to investigate the
properties of BNNTs in biological systems where the toxicity of
CNTs is troublesome.
Pristine multiwalled BNNTs were synthesized by a chemical
vapor deposition process adapted from a previously reported
method.
18 Slight modiﬁcations of experimental procedures were
made to produce highly pure BNNTs to fulﬁll the requirement for
cellular studies. Scanning electron microscopy (SEM) and transmis-
sion electron microscopy (TEM) investigations revealed high-purity
and -quality multiwalled BNNTs with an outer diameter of ∼20-30
nm and a length of up to 10 mm (Figure S1). Similar to CNTs,
BNNTs aggregate into entangled bundles.
HEK 293 cells were cultured with BNNTs (at 100 mg/mL) for
4 days. For comparison, the cells were cultured similarly with two
types of commercially available multiwalled CNTs (MWCNTs)
with diameters and lengths similar to BNNTs, purchased from MER
corp. (AZ, USA) and NanoLab (MA, USA). The MWNTs were
used directly without further puriﬁcation. Both BNNTs and
MWCNTs formed aggregates in culture media. In control experi-
ments, the cells were cultured with media alone. Live cells were
counted each day (Figure 1a). Cells cultured with BNNTs were
indistinguishable from cells grown with media alone. In sharp
contrast, cells cultured with either type of MWCNTs were unable
to expand during the course of the experiment. Similar results were
obtained using CHO cells (not shown).
CNTs have been shown to induce apoptosis in HEK 293 cells.
7
We therefore tested the viability of cells cultured with BNNTs using
the Annexin V-FITC/propidium iodide (PI) assay. HEK 293 cells
incubated with BNNTs showed no increased staining with Annexin
V-FITC or PI for at least 4 days (Figure 1b). Thus, BNNTs do not
appear to inhibit cell growth or induce apoptotic pathways in the
cells. It should be noted that the high purity and quality of BNNTs
are crucial for their nontoxicity.
Similar to CNTs, BNNTs are not soluble in aqueous media, a
limitation that must be overcome for biological implementation.
Although some methods for solubilizing BNNTs have been
reported,
19,20 general functionalization strategies for interfacing
BNNTs with biomolecules and cells are lacking. We therefore
explored the use of amphipathic dendritic structures similar to those
we recently reported as coatings for CNTs.
21 As shown in Fig-
ure S2, the dendrimers comprise synthetic carbohydrate ligands at
the chain ends that enable speciﬁc binding to receptors in solution.
A pyrene group at the dendrimer focal point allows adsorption to
CNT surfaces through π-stacking and hydrophobic interactions. We
hypothesized that these dendrimers might also interact with the
isoelectronic BNNT surface, permitting speciﬁc binding to carbo-
hydrate-binding proteins (Figure 2a).
A panel of glycodendrimers (generation 2 and 3 [G-2] and [G-3])
displaying various glycans were synthesized,
21 and data from studies
using the [G-2] dendrimer with R-mannose moieties ([G-2] Man,
Figure S2) are shown in Figure 2. The [G-2] Man-coated BNNTs
were stable in aqueous solution for weeks, while the unfunction-
alized BNNTs precipitated very quickly (within 1 h) in water
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Figure 1. BNNTs are not cytotoxic. (a) BNNTs do not inhibit HEK 293
cell proliferation. (b) BNNTs have no effect on cell viability. HEK 293
cells were cultured with BNNTs or with media alone. Cell viability is
expressed as the percentage of viable cells compared to untreated controls.
Error bars represent the standard deviation for three replicates.
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presence of the glycodendrimers as an amorphous surface layer
(Figure S3). Similar results were obtained with other glycoden-
drimers (not shown).
On cell surfaces, carbohydrates serve the dual role of speciﬁc
molecular recognition via carbohydrate-binding receptors (lectins)
and resistance to biofouling.
22 We evaluated whether the glyco-
dendrimer coating we created on the BNNTs would mimic these
functions. To test speciﬁc binding, BNNTs coated with [G-2] Man
were incubated with the R-mannose-speciﬁc receptor CanaValia
ensiformis agglutinin (Con A) conjugated to ﬂuorescein (FITC).
Unbound lectin was removed by dialysis, and the labeled BNNTs
were analyzed by ﬂuorescent spectroscopy (Figure S4). Signiﬁcant
ﬂuorescence was associated with Con A-bound [G-2] Man-BNNTs,
while only background ﬂuorescence was observed when the BNNTs
were labeled with FITC-conjugated Helix pomatia agglutinin
(HPA), a GalNAc-speciﬁc lectin that does not recognize mannose.
Thus, glycodendrimer-functionalized BNNTs can bind to proteins
via ligand-receptor interactions while resisting nonspeciﬁc binding
of irrelevant proteins.
We used the glycodendrimer coating to speciﬁcally bind BNNTs
directly to cell surfaces, an even more rigorous test of their
biocompatibility. We previously showed that ConA is capable of
cross-linking [G-2] Man-coated CNTs to cells by virtue of its
tetravalent nature.
21 Using the same approach, we bound Con
A-labeled [G-2] Man-coated BNNTs to the surface of CHO cells.
Fluorescence microscopy analysis revealed robust cell surface
ﬂuorescence from FITC (Figure 2c). As a control, BNNTs coated
with a similar [G-2] dendrimer bearing galactose residues ([G-2]
Gal), which do not bind to Con A, showed no ﬂuorescent labeling
of the cells (Figure S5). Importantly, we did not see any cellular
toxicity even when BNNTs were directly bound to the cell surface.
One of the most exciting applications of CNTs is to serve as a
molecular transporter to deliver biological molecules such as
proteins and DNA into living cells.
4,5 Given their similar dimen-
sions, BNNTs might be similarly employed but without any
unwanted toxic side effects. We explored their use as cell delivery
agents using single-stranded DNA (ssDNA) as cargo. We loaded a
synthetic 20-mer DNA oligomer conjugated to FITC onto the
surface of BNNTs by passive adsorption, as previously achieved
with CNTs.
23 BNNTs were sonicated with the FITC-labeled ssDNA
(FITC-DNA) in aqueous solution, and the resulting suspension was
stable in water and physiological buffers for at least several days.
CHO cells were then incubated with the FITC-DNA-BNNTs for
12 h. Fluorescence microscopy revealed that FITC-DNA-BNNTs
were internalized by the cells in a manner dependent on the carrier
BNNT (Figure 2d). In a control experiment, cells treated with FITC-
DNA alone, without a BNNT carrier, showed no signiﬁcant
ﬂuorescence above background (Figure S6).
In summary, we have showed that highly pure BNNTs are not
cytotoxic, suggesting that their use in therapeutic or diagnostic
applications should be seriously considered. Furthermore, we
demonstrated that BNNTs can be surface functionalized with
bioactive conjugates by noncovalent adsorption. This simple process
enables the surface display of glycodendrimers capable of interact-
ing with proteins and cells. Other biological epitopes such as
proteins, DNA, and RNA can be displayed in a similar fashion.
The method should facilitate applications of BNNTs in biosensing
and bioimaging without limitations imposed by cytotoxicity. More
generally, the observed properties of BNNTs are highly encouraging
for their application in biocompatible materials.
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Figure 2. (a) Schematic assembly of glycodendrimers on BNNT surface
in aqueous media. (b) Photographs of vials containing BNNT suspensions:
[G-2] Man-BNNTs (left) and uncoated BNNTs (right). (c) CHO cell surface
binding of [G-2] Man-BNNTs. FITC-conjugated Con A was prebound to
[G-2] Man-BNNTs. FITC-Con A-[G-2] Man-BNNT conjugates were
incubated with CHO cells and imaged by ﬂuorescence microscopy. The
cell nuclei were counterstained with DAPI. (d) CHO cells after internaliza-
tion of BNNTs coated with FITC-labeled DNA. CHO cells were incubated
with FITC-DNA-BNNTs overnight and stained with DAPI prior to
microscopy analysis.
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